IRADIMED CORPORATION (IRMD)

IRADIMED CORPORATION Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	80.51	73.24	65.56	53.3	41.81	31.72
Revenue Growth (YoY)	12.91%	11.71%	23.00%	27.47%	31.84%	-17.65%
Cost of Revenue	18.46	16.89	15.4	12.02	9.76	8.14
Gross Profit	62.05	56.35	50.16	41.28	32.05	23.57
Selling, General & Admin	34.49	31.59	27.3	23.41	20.36	19.76
Research & Development	2.71	2.8	2.82	2.24	1.87	1.87
Operating Expenses	37.2	34.39	30.12	25.65	22.23	21.63
Operating Income	24.85	21.96	20.04	15.63	9.82	1.94
Interest & Investment Income	2.19	2.19	1.86	0.58	0.03	0.13
Currency Exchange Gain (Loss)	-0.04	-0.04	-0.15	-0.04	-0.03	-0.01
Other Non Operating Income (Expenses)	-0.09	0.16	-	-	-	-
EBT Excluding Unusual Items	26.92	24.28	21.75	16.17	9.82	2.07
Gain (Loss) on Sale of Investments	-	-	-	0.01	0.02	0.02
Gain (Loss) on Sale of Assets	-0	-0	-0.01	-	-	-
Other Unusual Items	-	-	-	-	-	-2.7
Pretax Income	26.91	24.28	21.74	16.18	9.84	-0.62
Income Tax Expense	5.73	5.04	4.55	3.35	0.51	-1.99
Net Income	21.18	19.23	17.19	12.83	9.33	1.37
Net Income to Common	21.18	19.23	17.19	12.83	9.33	1.37
Net Income Growth	13.73%	11.87%	34.02%	37.56%	581.19%	-85.78%
Shares Outstanding (Basic)	13	13	13	13	12	12
Shares Outstanding (Diluted)	13	13	13	13	13	12
Shares Change (YoY)	0.68%	0.48%	0.69%	0.36%	1.21%	1.33%
EPS (Basic)	1.67	1.52	1.36	1.02	0.76	0.11
EPS (Diluted)	1.65	1.50	1.35	1.02	0.74	0.11
EPS Growth	13.00%	11.11%	32.35%	37.84%	572.73%	-85.90%
Free Cash Flow	14.75	17.62	6.02	9.22	10.78	5.37
Free Cash Flow Per Share	1.15	1.38	0.47	0.73	0.86	0.43
Dividend Per Share	0.680	0.470	0.150	-	-	-
Dividend Growth	51.11%	213.33%	-	-	-	-
Gross Margin	77.07%	76.94%	76.50%	77.45%	76.65%	74.33%
Operating Margin	30.87%	29.99%	30.56%	29.32%	23.48%	6.13%
Profit Margin	26.31%	26.26%	26.22%	24.07%	22.30%	4.32%
Free Cash Flow Margin	18.32%	24.06%	9.19%	17.30%	25.77%	16.95%
EBITDA	25.83	22.78	20.8	16.3	11.22	3.28
EBITDA Margin	32.09%	31.11%	31.73%	30.58%	26.84%	10.35%
D&A For EBITDA	0.98	0.82	0.77	0.67	1.41	1.34
EBIT	24.85	21.96	20.04	15.63	9.82	1.94
EBIT Margin	30.87%	29.99%	30.56%	29.32%	23.48%	6.13%
Effective Tax Rate	21.29%	20.77%	20.91%	20.72%	5.19%	-

Updated Nov 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q